Cowpox virus protein CPXV012 eludes CTLs by blocking ATP binding to TAP

Journal of Immunology

Volumn 193, Issue 4, 2014, Pages 1578-1589

  Luteijn, Rutger D ^a   Hoelen, Hanneke ^a   Kruse, Elisabeth ^a   Van Leeuwen, Wouter F ^a   Grootens, Jennine ^a   Horst, Daniëlle ^a   Koorengevel, Martijn ^b   Drijfhout, Jan W ^c   Kremmer, Elisabeth ^d   Früh, Klaus ^e   Neefjes, Jacques J ^f   Killian, Antoinette ^b   Lebbink, Robert Jan ^a   Ressing, Maaike E ^a,c   Wiertz, Emmanuel J H J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARRIER PROTEIN; PHOSPHOLIPID; PROTEIN CPXV012; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BIOPHYSICS; CONTROLLED STUDY; COWPOX VIRUS; CPXV012 GENE; CYTOTOXIC T LYMPHOCYTE; ENDOPLASMIC RETICULUM; FRAMESHIFT MUTATION; GENE DELETION; HUMAN; HUMAN CELL; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SEQUENCE ALIGNMENT;

ADENOSINE TRIPHOSPHATE; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CELL MEMBRANE; COWPOX VIRUS; ENDOPLASMIC RETICULUM; FRAMESHIFT MUTATION; HEK293 CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNE EVASION; PROTEIN BINDING; PROTEIN TRANSPORT; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 84905969295     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400964     Document Type: Article

References (55)

1. Yewdell, J. W., E. Reits, and J. Neefjes. 2003. Making sense of mass destruction: Quantitating MHC class I antigen presentation. Nat. Rev. Immunol. 3: 952-961.
2. Vos, J. C., P. Spee, F. Momburg, and J. Neefjes. 1999. Membrane topology and dimerization of the two subunits of the transporter associated with antigen processing reveal a three-domain structure. J. Immunol. 163: 6679-6685.
3. Vos, J. C., E. A. Reits, E. Wojcik-Jacobs, and J. Neefjes. 2000. Head-head/tailtail relative orientation of the pore-forming domains of the heterodimeric ABC transporter TAP. Curr. Biol. 10: 1-7.
4. Procko, E., and R. Gaudet. 2009. Antigen processing and presentation: TAPping into ABC transporters. Curr. Opin. Immunol. 21: 84-91.
5. Sadasivan, B., P. J. Lehner, B. Ortmann, T. Spies, and P. Cresswell. 1996. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5: 103-114.
6. Procko, E., G. Raghuraman, D. C. Wiley, M. Raghavan, and R. Gaudet. 2005. Identification of domain boundaries within the N-termini of TAP1 and TAP2 and their importance in tapasin binding and tapasin-mediated increase in peptide loading of MHC class I. Immunol. Cell Biol. 83: 475-482.
7. Hansen, T. H., and M. Bouvier. 2009. MHC class I antigen presentation: Learning from viral evasion strategies. Nat. Rev. Immunol. 9: 503-513.
8. Ahn, K., T. H. Meyer, S. Uebel, P. Sempé, H. Djaballah, Y. Yang, P. A. Peterson, K. Früh, and R. Tampé. 1996. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 15: 3247-3255.
9. Früh, K., K. Ahn, H. Djaballah, P. Sempé, P. M. Van Endert, R. Tampé, P. A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375: 415-418.
10. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375: 411-415.
11. Ahn, K., A. Gruhler, B. Galocha, T. R. Jones, E. J. Wiertz, H. L. Ploegh, P. A. Peterson, Y. Yang, and K. Früh. 1997. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6: 613-621.
12. Hengel, H., J. O. Koopmann, T. Flohr, W. Muranyi, E. Goulmy, G. J. Hämmerling, U. H. Koszinowski, and F. Momburg. 1997. A viral ERresident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6: 623-632.
13. Hewitt, E. W., S. S. Gupta, and P. J. Lehner. 2001. The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J. 20: 387-396.
14. Koppers-Lalic, D., E. A. Reits, M. E. Ressing, A. D. Lipinska, R. Abele, J. Koch, M. Marcondes Rezende, P. Admiraal, D. Van Leeuwen, K. Bienkowska-Szewczyk, et al. 2005. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc. Natl. Acad. Sci. USA 102: 5144-5149.
15. Koppers-Lalic, D., M. C. Verweij, A. D. Lipi-nska, Y. Wang, E. Quinten, E. A. Reits, J. Koch, S. Loch, M. Marcondes Rezende, F. Daus, et al. 2008. Varicellovirus UL 49.5 proteins differentially affect the function of the transporter associated with antigen processing, TAP. PLoS Pathog. 4: E1000080.
16. Hislop, A. D., M. E. Ressing, D. Van Leeuwen, V. A. Pudney, D. Horst, D. Koppers-Lalic, N. P. Croft, J. J. Neefjes, A. B. Rickinson, and E. J. Wiertz. 2007. A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates. J. Exp. Med. 204: 1863-1873.
17. Alzhanova, D., D. M. Edwards, E. Hammarlund, I. G. Scholz, D. Horst, M. J. Wagner, C. Upton, E. J. Wiertz, M. K. Slifka, and K. Früh. 2009. Cowpox virus inhibits the transporter associated with antigen processing to evade T cell recognition. Cell Host Microbe 6: 433-445.
18. Byun, M., M. C. Verweij, D. J. Pickup, E. J. Wiertz, T. H. Hansen, and W. M. Yokoyama. 2009. Two mechanistically distinct immune evasion proteins of cowpox virus combine to avoid antiviral CD8 T cells. Cell Host Microbe 6: 422-432.
19. Alzhanova, D., and K. Früh. 2010. Modulation of the host immune response by cowpox virus. Microbes Infect. 12: 900-909.
20. Byun, M., X.Wang, M. Pak, T. H. Hansen, andW. M. Yokoyama. 2007. Cowpox virus exploits the endoplasmic reticulum retention pathway to inhibit MHC class I transport to the cell surface. Cell Host Microbe 2: 306-315.
21. Van Ham, S. M., E. P. Tjin, B. F. Lillemeier, U. Grüneberg, K. E. Van Meijgaarden, L. Pastoors, D. Verwoerd, A. Tulp, B. Canas, D. Rahman, et al. 1997. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr. Biol. 7: 950-957.
22. Reits, E. A., J. C. Vos, M. Grommé, and J. Neefjes. 2000. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 404: 774-778.
23. Heemskerk, M. H., E. Hooijberg, J. J. Ruizendaal, M. M. Van Der Weide, E. Kueter, A. Q. Bakker, T. N. Schumacher, and H. Spits. 1999. Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells. Cell. Immunol. 195: 10-17.
24. Norment, A. M., N. Lonberg, E. Lacy, and D. R. Littman. 1989. Alternatively spliced mRNA encodes a secreted form of human CD8 alpha. Characterization of the human CD8 alpha gene. J. Immunol. 142: 3312-3319.
25. Alvarez, E., N. Gironès, and R. J. Davis. 1990. Inhibition of the receptormediated endocytosis of diferric transferrin is associated with the covalent modification of the transferrin receptor with palmitic acid. J. Biol. Chem. 265: 16644-16655.
26. Hiemstra, H. S., G. Duinkerken, W. E. Benckhuijsen, R. Amons, R. R. De Vries, B. O. Roep, and J. W. Drijfhout. 1997. The identification of CD4+ T cell epitopes with dedicated synthetic peptide libraries. Proc. Natl. Acad. Sci. USA 94: 10313-10318.
27. Neefjes, J. J., F. Momburg, and G. J. Hämmerling. 1993. Selective and ATPdependent translocation of peptides by the MHC-encoded transporter. Science 261: 769-771.
28. Spee, P., J. Subjeck, and J. Neefjes. 1999. Identification of novel peptide binding proteins in the endoplasmic reticulum: ERp72, calnexin, and grp170. Biochemistry 38: 10559-10566.
29. Khemtémourian, L., G. Lahoz Casarramona, D. P. Suylen, T. M. Hackeng, J. D. Meeldijk, B. De Kruijff, J. W. Höppener, and J. A. Killian. 2009. Impaired processing of human pro-islet amyloid polypeptide is not a causative factor for fibril formation or membrane damage in vitro. Biochemistry 48: 10918-10925.
30. Parcej, D., and R. Tampé. 2010. ABC proteins in antigen translocation and viral inhibition. Nat. Chem. Biol. 6: 572-580.
31. Procko, E., M. L. O'Mara, W. F. Bennett, D. P. Tieleman, and R. Gaudet. 2009. The mechanism of ABC transporters: General lessons from structural and functional studies of an antigenic peptide transporter. FASEB J. 23: 1287-1302.
32. Van Meer, G., D. R. Voelker, and G. W. Feigenson. 2008. Membrane lipids: Where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9: 112-124.
33. Demel, R. A., W. S. Geurts Van Kessel, R. F. Zwaal, B. Roelofsen, and L. L. Van Deenen. 1975. Relation between various phospholipase actions on human red cell membranes and the interfacial phospholipid pressure in monolayers. Biochim. Biophys. Acta 406: 97-107.
34. Grandea, A. G., III, T. N. Golovina, S. E. Hamilton, V. Sriram, T. Spies, R. R. Brutkiewicz, J. T. Harty, L. C. Eisenlohr, and L. Van Kaer. 2000. Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice. Immunity 13: 213-222.
35. Horst, D., D. Van Leeuwen, N. P. Croft, M. A. Garstka, A. D. Hislop, E. Kremmer, A. B. Rickinson, E. J. Wiertz, and M. E. Ressing. 2009. Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation. J. Immunol. 182: 2313-2324.
36. Zernich, D., A. W. Purcell, W. A. Macdonald, L. Kjer-Nielsen, L. K. Ely, N. Laham, T. Crockford, N. A. Mifsud, M. Bharadwaj, L. Chang, et al. 2004. Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. J. Exp. Med. 200: 13-24.
37. Verweij, M. C., D. Koppers-Lalic, S. Loch, F. Klauschies, H. De La Salle, E. Quinten, P. J. Lehner, A. Mulder, M. R. Knittler, R. Tampé, et al. 2008. The varicellovirus UL49.5 protein blocks the transporter associated with antigen processing (TAP) by inhibiting essential conformational transitions in the 6+6 transmembrane TAP core complex. J. Immunol. 181: 4894-4907.
38. Dabrowski, P. W., A. Radonić, A. Kurth, and A. Nitsche. 2013. Genome-wide comparison of cowpox viruses reveals a new clade related to Variola virus. PLoS ONE 8: E79953.
39. Aisenbrey, C., C. Sizun, J. Koch, M. Herget, R. Abele, B. Bechinger, and R. Tampé. 2006. Structure and dynamics of membrane-associated ICP47, a viral inhibitor of the MHC I antigen-processing machinery. J. Biol. Chem. 281: 30365-30372.
40. Beinert, D., L. Neumann, S. Uebel, and R. Tampé. 1997. Structure of the viral TAP-inhibitor ICP47 induced by membrane association. Biochemistry 36: 4694-4700.
41. Kyritsis, C., S. Gorbulev, S. Hutschenreiter, K. Pawlitschko, R. Abele, and R. Tampé. 2001. Molecular mechanism and structural aspects of transporter associated with antigen processing inhibition by the cytomegalovirus protein US6. J. Biol. Chem. 276: 48031-48039.
42. Calvez, P., S. Bussières, Eric Demers, and C. Salesse. 2009. Parameters modulating the maximum insertion pressure of proteins and peptides in lipid monolayers. Biochimie 91: 718-733.
43. Killian, J. A., and G. von Heijne. 2000. How proteins adapt to a membrane-water interface. Trends Biochem. Sci. 25: 429-434.
44. Abel, E., S. L. De Wall, W. B. Edwards, S. Lalitha, D. F. Covey, and G. W. Gokel. 2000. Formation of stable vesicles from N-or 3-alkylindoles: Possible evidence for tryptophan as a membrane anchor in proteins. J. Org. Chem. 65: 5901-5909.
45. Strandberg, E., and J. A. Killian. 2003. Snorkeling of lysine side chains in transmembrane helices: How easy can it get? FEBS Lett. 544: 69-73.
46. Yau, W. M., W. C. Wimley, K. Gawrisch, and S. H. White. 1998. The preference of tryptophan for membrane interfaces. Biochemistry 37: 14713-14718.
47. Neumann, L., W. Kraas, S. Uebel, G. Jung, and R. Tampé. 1997. The active domain of the herpes simplex virus protein ICP47: A potent inhibitor of the transporter associated with antigen processing. J. Mol. Biol. 272: 484-492.
48. Eiríksdóttir, E., K. Konate, U. Langel, G. Divita, and S. Deshayes. 2010. Secondary structure of cell-penetrating peptides controls membrane interaction and insertion. Biochim. Biophys. Acta 1798: 1119-1128.
49. Geng, J., S. Sivaramakrishnan, and M. Raghavan. 2013. Analyses of conformational states of the transporter associated with antigen processing (TAP) protein in a native cellular membrane environment. J. Biol. Chem. 288: 37039-37047.
50. Crowley, E., M. L. O'Mara, I. D. Kerr, and R. Callaghan. 2010. Transmembrane helix 12 plays a pivotal role in coupling energy provision and drug binding in ABCB1. FEBS J. 277: 3974-3985.
51. Kueppers, P., R. P. Gupta, J. Stindt, S. H. Smits, and L. Schmitt. 2013. Functional impact of a single mutation within the transmembrane domain of the multidrug ABC transporter Pdr5. Biochemistry 52: 2184-2195.
52. Halenius, A., F. Momburg, H. Reinhard, D. Bauer, M. Lobigs, and H. Hengel. 2006. Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing. J. Biol. Chem. 281: 5383-5390.
53. Horst, D., V. Favaloro, F. Vilardi, H. C. Van Leeuwen, M. A. Garstka, A. D. Hislop, C. Rabu, E. Kremmer, A. B. Rickinson, S. High, et al. 2011. EBV protein BNLF2a exploits host tail-anchored protein integration machinery to inhibit TAP. J. Immunol. 186: 3594-3605.
54. Waterhouse, A. M., J. B. Procter, D. M. Martin, M. Clamp, and G. J. Barton. 2009. Jalview Version 2-A multiple sequence alignment editor and analysis workbench. Bioinformatics 25: 1189-1191.
55. Zhang, Y. 2008. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9: 40.